The corrected QT interval prolongation in adolescents with cardiac iron overload β-thalassemia major

Najib Advani1, Najib Advani1, Murti Andriastuti1

  • 1Department of Child Health, Faculty of Medicine Universitas Indonesia-Cipto Mangunkusumo Hospital, Jakarta, Indonesia.

Insights

QTc interval prolongation indicates cardiac iron overload in adolescent beta-thalassemia major patients. This electrocardiogram (ECG) finding can serve as an accessible early detection marker for heart conditions.

Area of Science:

  • Cardiology
  • Pediatrics
  • Medical Imaging

Background:

  • Iron-induced cardiomyopathy is a major cause of mortality in beta-thalassemia major.
  • T2* magnetic resonance imaging (MRI) is the gold standard for iron load detection but is costly and inaccessible in many regions.
  • Previous research suggests QTc interval may predict cardiac iron overload.

Purpose of the Study:

  • To assess the diagnostic value of QTc interval for early detection of cardiac iron overload in adolescents with beta-thalassemia major.
  • To evaluate QTc interval as a potential screening tool in resource-limited settings.

Main Methods:

  • Prospective evaluation of QTc interval in 50 beta-thalassemia major patients (aged 10-18 years).
  • All participants underwent 12-lead ECG, echocardiogram, and cardiac MRI T2* within three months.
  • Patients were classified into cardiac iron overload (MRI T2* < 20 ms) and non-cardiac iron overload (MRI T2* > 20 ms) groups.

Main Results:

  • No significant systolic or diastolic dysfunction was observed via echocardiography.
  • A significant difference in mean QTc interval was found between the cardiac iron overload (464.44 ± 20.35 ms) and non-cardiac iron overload (431.09 ± 32.29 ms) groups (p=0.001).
  • The QTc interval demonstrated diagnostic utility with an AUC of 0.8 (p=0.002), sensitivity of 0.88, and specificity of 0.73 at a cut-off of 449 ms.

Conclusions:

  • Cardiac iron overload is associated with QTc interval prolongation in adolescents.
  • A QTc interval of 449 ms can be considered a potential cut-off for identifying cardiac iron overload in this population.
Abstract

Related Concept Videos

Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
175
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
2.1K
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
277
Dysrhythmias VII: Nursing Management of Dysrhythmias01:25

Dysrhythmias VII: Nursing Management of Dysrhythmias

Nursing management of dysrhythmias involves the following:AssessmentSubjective Assessment:The initial step involves gathering patient-reported symptoms such as dizziness, palpitations, and chest discomfort. It is crucial to collect a detailed history, including previous heart conditions, current medication use, and lifestyle factors like caffeine and alcohol consumption.Objective Assessment:This involves observing clinical signs such as jugular venous distention, cool and pale skin, and...
264
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
330
Increased pulse rate01:17

Increased pulse rate

Tachycardia is a condition marked by an abnormally fast or irregular heart rate, surpassing the typical resting rate. In adults, tachycardia is characterized by a pulse rate ranging from 100 to 180 beats per minute. The increased heart rate can result in inadequate blood flow to various body parts, ultimately diminishing the oxygen supply to organs and tissues.
Many factors can elevate the risk of developing tachycardia. These include advanced age, a family history of arrhythmias, and an...
966